This article was originally published in The Gray Sheet
CMS national coverage decision will catalyze home-use of blood microcoagulation testing system in $100 mil. market, cardiovascular firm claims June 3. Manufactured and marketed by Thoratec's International Technidyne Corporation (ITC) division, the ProTime measures prothrombin time in patients with a mechanical heart valve and who are taking blood-thinning drugs. Medicare reimbursement is currently available only for testing done at a physician's office or lab. New coverage for the equipment is expected to become effective on July 1, 2002...
You may also be interested in...
Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated.
Sanofi R&D head John Reed says the company has kept 95% of patients on its nearly 400 clinical trials, started 59 studies, and benefited from its in-house drug supply management.
The funding will be used to support clinical and preclinical development at its portfolio companies, with 8-10 programs in the clinic in 2021.